Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warrantedResearch in context
Summary: Background: SARS-CoV-2-neutralizing antibodies (nABs) showed great promise in the early phases of the COVID-19 pandemic. The emergence of resistant strains, however, quickly rendered the majority of clinically approved nABs ineffective. This underscored the imperative to develop nAB cockta...
Main Authors: | Delphine Diana Acar, Wojciech Witkowski, Magdalena Wejda, Ruifang Wei, Tim Desmet, Bert Schepens, Sieglinde De Cae, Koen Sedeyn, Hannah Eeckhaut, Daria Fijalkowska, Kenny Roose, Sandrine Vanmarcke, Anne Poupon, Dirk Jochmans, Xin Zhang, Rana Abdelnabi, Caroline S. Foo, Birgit Weynand, Dirk Reiter, Nico Callewaert, Han Remaut, Johan Neyts, Xavier Saelens, Sarah Gerlo, Linos Vandekerckhove |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396423005261 |
Similar Items
-
Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses.
by: Koen Sedeyn, et al.
Published: (2019-10-01) -
Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
by: Caroline S. Foo, et al.
Published: (2022-03-01) -
Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment
by: Rana Abdelnabi, et al.
Published: (2023-04-01) -
How RSV Proteins Join Forces to Overcome the Host Innate Immune Response
by: Tessa Van Royen, et al.
Published: (2022-02-01) -
Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity
by: Bram Van Den Eeckhout, et al.
Published: (2023-10-01)